Shih‐Ming Huang

5.8k total citations · 1 hit paper
153 papers, 4.5k citations indexed

About

Shih‐Ming Huang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Shih‐Ming Huang has authored 153 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Molecular Biology, 33 papers in Cancer Research and 28 papers in Oncology. Recurrent topics in Shih‐Ming Huang's work include Cancer, Hypoxia, and Metabolism (17 papers), RNA modifications and cancer (13 papers) and Cancer-related gene regulation (13 papers). Shih‐Ming Huang is often cited by papers focused on Cancer, Hypoxia, and Metabolism (17 papers), RNA modifications and cancer (13 papers) and Cancer-related gene regulation (13 papers). Shih‐Ming Huang collaborates with scholars based in Taiwan, United States and India. Shih‐Ming Huang's co-authors include Michael R. Stallcup, Dagang Chen, Dana W. Aswad, Brandon T. Schurter, Heng Hong, Han Ma, Stephen S. Koh, Shuting Liu, Yung‐Lung Chang and James Yi‐Hsin Chan and has published in prestigious journals such as Science, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Shih‐Ming Huang

150 papers receiving 4.4k citations

Hit Papers

Regulation of Transcription by a Protein Methyltransferase 1999 2026 2008 2017 1999 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Regulation of Transcription by a Protein Methyltransferase
    1999 981 citations Shih‐Ming Huang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shih‐Ming Huang Taiwan 32 2.8k 691 633 560 422 153 4.5k
Ni Wang China 34 1.5k 0.6× 477 0.7× 420 0.7× 379 0.7× 299 0.7× 181 3.5k
Wei Xu China 35 2.0k 0.7× 1.2k 1.7× 518 0.8× 610 1.1× 494 1.2× 172 4.6k
Fuu‐Jen Tsai Taiwan 35 1.6k 0.6× 376 0.5× 375 0.6× 450 0.8× 334 0.8× 275 4.2k
Masato Maekawa Japan 33 1.6k 0.6× 565 0.8× 316 0.5× 604 1.1× 486 1.2× 222 3.9k
Li Ma China 40 1.7k 0.6× 410 0.6× 311 0.5× 610 1.1× 748 1.8× 172 4.9k
Zhenyu Ju China 41 2.8k 1.0× 699 1.0× 242 0.4× 665 1.2× 330 0.8× 151 5.6k
Liang Li China 31 2.0k 0.7× 721 1.0× 258 0.4× 981 1.8× 314 0.7× 179 3.9k
Sheng Li China 32 2.2k 0.8× 763 1.1× 187 0.3× 548 1.0× 483 1.1× 155 3.6k
Bing Li China 32 2.2k 0.8× 1.0k 1.5× 230 0.4× 682 1.2× 804 1.9× 198 4.4k
Nengtai Ouyang United States 29 1.8k 0.7× 614 0.9× 410 0.6× 690 1.2× 338 0.8× 85 3.5k

Countries citing papers authored by Shih‐Ming Huang

Since Specialization
Citations

This map shows the geographic impact of Shih‐Ming Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shih‐Ming Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shih‐Ming Huang more than expected).

Fields of papers citing papers by Shih‐Ming Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shih‐Ming Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shih‐Ming Huang. The network helps show where Shih‐Ming Huang may publish in the future.

Co-authorship network of co-authors of Shih‐Ming Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Shih‐Ming Huang. A scholar is included among the top collaborators of Shih‐Ming Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shih‐Ming Huang. Shih‐Ming Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Yi‐Hsuan, et al.. (2025). O-Desmethyltramadol Enhanced Anti-Cancer Efficacy over Tramadol Through Non-μ-Opioid Receptor and Differential Cellular Contexts of Human Breast Cancer Cells. International Journal of Molecular Sciences. 26(9). 4139–4139. 1 indexed citations
2.
Chen, Dyi‐Cheng, et al.. (2024). Applying the Taguchi Method to Improve Key Parameters of Extrusion Vacuum-Forming Quality. Polymers. 16(8). 1113–1113. 1 indexed citations
3.
Chen, Jialin, Shuting Liu, Chia‐Chun Wu, Yi‐Chou Chen, & Shih‐Ming Huang. (2024). The Potency of Cytotoxic Mechanisms of Local Anesthetics in Human Chondrocyte Cells. International Journal of Molecular Sciences. 25(24). 13474–13474. 1 indexed citations
4.
Liu, Shuting, et al.. (2023). Oxidative Status Determines the Cytotoxicity of Ascorbic Acid in Human Oral Normal and Cancer Cells. International Journal of Molecular Sciences. 24(5). 4851–4851. 4 indexed citations
5.
6.
Chiu, Yi‐Lin, et al.. (2023). Exploring the Functional Roles of Telomere Maintenance 2 in the Tumorigenesis of Glioblastoma Multiforme and Drug Responsiveness to Temozolomide. International Journal of Molecular Sciences. 24(11). 9256–9256. 4 indexed citations
7.
Huang, Li‐Chun, et al.. (2022). The Effect of Disulfiram and Copper on Cellular Viability, ER Stress and ALDH Expression of Human Meningioma Cells. Biomedicines. 10(4). 887–887. 5 indexed citations
8.
Huang, Yi‐Hsuan, et al.. (2022). Antitumorigenic Effect of Tramadol and Synergistic Effect With Doxorubicin in Human Breast Cancer Cells. Frontiers in Oncology. 12. 811716–811716. 9 indexed citations
9.
Chen, Jialin, Shuting Liu, Shih‐Ming Huang, & Zhi‐Fu Wu. (2022). Apoptosis, Proliferation, and Autophagy Are Involved in Local Anesthetic-Induced Cytotoxicity of Human Breast Cancer Cells. International Journal of Molecular Sciences. 23(24). 15455–15455. 11 indexed citations
10.
Yang, Hsiang‐Yu, et al.. (2022). The Role of Sirtuin 1 in Palmitic Acid-Induced Endoplasmic Reticulum Stress in Cardiac Myoblasts. Life. 12(2). 182–182. 7 indexed citations
11.
Chen, Hsuan‐Yu, et al.. (2022). Exploring the Mechanism of Adjuvant Treatment of Glioblastoma Using Temozolomide and Metformin. International Journal of Molecular Sciences. 23(15). 8171–8171. 25 indexed citations
12.
Tseng, Min‐Hua, Shih‐Ming Huang, Martin Konrad, et al.. (2021). Effect of Hydrocortisone on Angiotensinogen (AGT) Mutation–Causing Autosomal Recessive Renal Tubular Dysgenesis. Cells. 10(4). 782–782. 2 indexed citations
13.
Chang, Yung‐Lung, et al.. (2021). Differential Cytotoxicity Mechanisms of Copper Complexed with Disulfiram in Oral Cancer Cells. International Journal of Molecular Sciences. 22(7). 3711–3711. 27 indexed citations
14.
Huang, Shih‐Ming, et al.. (2021). Palmitate Enhances the Efficacy of Cisplatin and Doxorubicin against Human Endometrial Carcinoma Cells. International Journal of Molecular Sciences. 23(1). 80–80. 12 indexed citations
15.
Li, Yao‐Feng, Chung-Hsing Chou, Li‐Chun Huang, et al.. (2021). GRPEL2 Knockdown Exerts Redox Regulation in Glioblastoma. International Journal of Molecular Sciences. 22(23). 12705–12705. 7 indexed citations
16.
Liu, Shuting, et al.. (2019). Regulatory mechanisms of fluvastatin and lovastatin for the p21 induction in human cervical cancer HeLa cells. PLoS ONE. 14(4). e0214408–e0214408. 11 indexed citations
17.
Liu, Shuting, et al.. (2018). Metformin causes cancer cell death through downregulation of p53-dependent differentiated embryo chondrocyte 1. Journal of Biomedical Science. 25(1). 81–81. 31 indexed citations
18.
Tang, Shou‐Hung, Sheng‐Tang Wu, Yu‐Chi Chen, et al.. (2015). Novel Cancer Therapeutics with Allosteric Modulation of the Mitochondrial C-Raf–DAPK Complex by Raf Inhibitor Combination Therapy. Cancer Research. 75(17). 3568–3582. 18 indexed citations
19.
Cha, Tai‐Lung, Shou‐Hung Tang, Sheng‐Tang Wu, et al.. (2013). Emodin modulates epigenetic modifications and suppresses bladder carcinoma cell growth. Molecular Carcinogenesis. 54(3). 167–177. 35 indexed citations
20.
Huang, Shih‐Ming, et al.. (2013). Caffeine induces tumor cytotoxicity via the regulation of alternative splicing in subsets of cancer-associated genes. The International Journal of Biochemistry & Cell Biology. 47. 83–92. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ni Wang Breakdown of academic impact, for papers by Wei Xu Breakdown of academic impact, for papers by Fuu‐Jen Tsai Breakdown of academic impact, for papers by Masato Maekawa Breakdown of academic impact, for papers by Li Ma Breakdown of academic impact, for papers by Zhenyu Ju Breakdown of academic impact, for papers by Liang Li Breakdown of academic impact, for papers by Sheng Li Breakdown of academic impact, for papers by Bing Li Breakdown of academic impact, for papers by Nengtai Ouyang
Rankless by CCL
2026